1. Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus- Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA- Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning 
Frédéric Baron, Chantal Lechanteur, Evelyne Willems, France Bruck, Etienne Baudoux, Laurence Seidel, Jean-François Vanbellinghen, Kaoutar Hafraoui, Marie Lejeune, André Gothot, Georges Fillet, Yves Beguin 
Biology of Blood and Marrow Transplantation 
Volume 16, Issue 6, Pages (June 2010)
DOI: /j.bbmt
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
T cell engraftment kinetics (donor T cell chimerism levels) in MSC patients (white bars) and in historic patients (black bars).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
(A) Cumulative incidence of grade II-IV aGVHD in study patients given MSC (MSC group, broken line) or in historic patients (solid line). (B) Cumulative incidence of moderate/severe cGVHD in study patients given MSC (MSC group, broken line) or in historic patients (solid line).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
OS (A) and PFS (B) in study patients given MSC (MSC group, broken line) or in historic patients (solid line).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions